Astrid Breitschaft did not receive direct payments or support for participating in the manuscript but is an employee of Parexel International, which received funding from Novo Nordisk to conduct the trial
Replenishing physiological levels of GHK-Cu has been shown to offer powerful regenerative and reparative longevity actions including collagen and elastin synthesis, DNA repair, stem cell renewal processes, restoring an appropriate inflammatory response, neurological and cardiovascular protection, and the reset of epigenetic programming.
Check your blood glucose if possible and seek medical advice if you experience recurrent episodes, as your medication doses may need adjustment
It cites average reductions of 2 to 6 mmHg systolic in many patients, while noting that weight loss itself contributes to that effect
Pharmaceutical trials exclude pregnant and nursing participants for ethical reasons, leaving lactation-specific data sparse
Most people notice improved confidence, better overall health, and a more positive daily lifestyle